摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(4-Fluorophenyl)-5-(2-methylsulfinylpyrimidin-5-yl)-1-ethoxymethyl-[1,2,3]triazole | 474511-94-9

中文名称
——
中文别名
——
英文名称
4-(4-Fluorophenyl)-5-(2-methylsulfinylpyrimidin-5-yl)-1-ethoxymethyl-[1,2,3]triazole
英文别名
5-[3-(Ethoxymethyl)-5-(4-fluorophenyl)triazol-4-yl]-2-methylsulfinylpyrimidine
4-(4-Fluorophenyl)-5-(2-methylsulfinylpyrimidin-5-yl)-1-ethoxymethyl-[1,2,3]triazole化学式
CAS
474511-94-9
化学式
C16H16FN5O2S
mdl
——
分子量
361.4
InChiKey
UPSXLWDRFXRSKO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    25
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    102
  • 氢给体数:
    0
  • 氢受体数:
    8

文献信息

  • [EN] TRIAZOLE COMPOUNDS USEFUL IN TREATING DISEASES ASSOCIATED WITH UNWANTED CYTOKINE ACTIVITY<br/>[FR] COMPOSES TRIAZOLE CONVENANT POUR LE TRAITEMENT DE MALADIES ASSOCIEES A L'ACTIVITE INDESIRABLE DES CYTOKINES
    申请人:PROCTER & GAMBLE
    公开号:WO2002088108A1
    公开(公告)日:2002-11-07
    The present invention relates to 4-aryl triazoles having the formula: wherein R1 is independently selected from the group consisting of: lower alkyl, lower alkenyl, lower alkynyl, lower heteroalkyl, lower heteroalkenyl, lower heteroalkynyl, heterocycloalkyl, heteroaryl, halo, CN, OR4, SR4, S(O)R4, S(O)2R4, and NR4R5; and Q is has the general formula: or said compounds are useful in treating diseases associated with unwanted cytokine activity, inter alia, interleukin-1 (IL-1) and tumor necrosis factor (TNF) from cells.
    本发明涉及具有以下式的4-芳基三唑:其中R1独立地选自以下组中的一种:低烷基,低烯基,低炔基,低杂原烷基,低杂原烯基,低杂原炔基,杂环烷基,杂环芳基,卤素,CN,OR4,SR4,S(O)R4,S(O)2R4和NR4R5;Q具有以下通式:或者说这些化合物在治疗与不必要的细胞因子活性相关的疾病方面有用,例如白细胞介素-1(IL-1)和肿瘤坏死因子(TNF)。
  • Triazole compounds useful in treating diseases associated with unwanted cytokine activity
    申请人:——
    公开号:US20030013712A1
    公开(公告)日:2003-01-16
    The present invention relates to 4-aryl triazoles having the formula: 1 wherein R 1 is independently selected from the group consisting of: lower alkyl, lower alkenyl, lower alkynyl, lower heteroalkyl, lower heteroalkenyl, lower heteroalkynyl, heterocycloalkyl, heteroaryl, halo, CN, OR 4 , SR 4 , S(O)R 4 , S(O) 2 R 4 , and NR 4 R 5 ; and Q is has the general formula: 2 said compounds are useful in treating diseases associated with unwanted cytokine activity, inter alia, interleukin-1 (IL-1) and tumor necrosis factor (TNF) from cells.
    本发明涉及具有以下式子的4-芳基三唑:1其中R1独立地选自以下组:低烷基,低烯基,低炔基,低杂原烷基,低杂原烯基,低杂原炔基,杂环烷基,杂环芳基,卤素,CN,OR4,SR4,S(O)R4,S(O)2R4和NR4R5; Q具有一般式:2所述化合物在治疗与细胞中不需要的细胞因子活性相关的疾病中有用,包括白细胞介素-1(IL-1)和肿瘤坏死因子(TNF)。
  • TRIAZOLE COMPOUNDS USEFUL IN TREATING DISEASES ASSOCIATED WITH UNWANTED CYTOKINE ACTIVITY
    申请人:The Procter & Gamble Company
    公开号:EP1383759A1
    公开(公告)日:2004-01-28
  • US6727364B2
    申请人:——
    公开号:US6727364B2
    公开(公告)日:2004-04-27
  • US6787555B2
    申请人:——
    公开号:US6787555B2
    公开(公告)日:2004-09-07
查看更多